000			03739nam a22002537a 4500
003			KENaKMTC
005			20250226131718.0
008			250226b |||||||| |||| 00| 0 eng d
020			_a9780323681353
020			_a9780323681360
020			_a0323681360
040			_cDLC
050			_aRC681.H47 2023
100			_aHerrmann joerg _eAuthor
245			_aCardio-oncology practice manual: _bAcompanion to braunwald's heart disease/ _cjoerg herrmann
260			_aPhiladelphia: _bElsevier, _cc2023
300			_axx,518pages: _bcolor illustrations; _c23cm
500			_aIncludes index
505			_aCONTENTS 1. The Cardio-Oncology Clinic:g0als,scope and focus of practice-- Part I. Cardiovascular Disease Management Before Cancer Treatment-- Section A. The A-to-Z Before Therapy-- 2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy -- 3. Chemotherapeutic Risks Before Cancer Therapy -- 4. Radiation Therapy Risks Before Cancer Therapy -- 5. Bone Marrow Transplantation Risks Before Cancer Therapy -- 6. Surgical Risks Before Cancer Therapy Section B. Cardiovascular Disease Prevention in Cancer Patients -- 7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy -- 8. Vascular Disease Prevention Before Cancer Therapy-- 9. Thromboembolic Disease Prevention Before Cancer Therapy -- 10. Arrhythmia Prevention and Device Management Before Cancer Therapy-- 11. Hypertension and Renal Disease Prevention Before Cancer Therapy-- 12. Pulmonary Disease Prevention Before Cancer Therapy -- 13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy Part II. Cardiovascular Disease Management During Cancer Treatment-- Section C. The A-to-Z Through Therapy -- 14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy -- 15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy -- 16. Structural Heart Disease -- 17. Vascular Disease -- 18. Thromboembolic Disease -- 19. Arrhythmia, QTc Prolongation, and Device Management -- 20. Hypertension and Renal Disease -- 21. Pulmonary Disease-- 22. Cardiovascular Imaging Part III. Cardiovascular Disease Management After Cancer Treatment Section D. The A-to-Z After Therapy -- 23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy -- 24. Cancer Survivorship and Co-Morbidity Disease Risk -- 25. Long-Term Complications of Chemotherapy -- 26. Long-Term Complications of Radiation Therapy Section E. Cardiovascular Disease in Cancer Survivors -- 27. Cardiomyopathy/Heart Failure Prevention and Management -- 28. Structureal Heart Disease Prevention and Management -- 29. Vascular Disease Prevention and Management-- 30. Thromboembolic Disease Prevention and Management -- 31. Arrhythmia Prevention and Management -- 32. Hypertension and Renal Failure Prevention and Management -- 33. Pulmonary Disease Prevention and Management -- 34. Cardiopulmonary Rehabilitation Section F. Cardiovascular Disease Management in Specific Malignant Diseases -- 35. Breast Cancer 36. Uterine, Ovary, and Cervical Cancer -- 37. Prostate and Testicular Cancer -- 38. Renal and Urinary Bladder Cancer -- 39. Lung Cancer 40. Colorectal Cancer -- 41. Esophageal and Gastric Cancer -- 42. Hepatobiliary Carcinomas -- 43. Pancreatic Cancer -- 44. Melanoma -- 45. Head-and-Neck Cancers -- 46. Thyroid cancer 47. Glioblastoma -- 48. Bone and Soft Tissue Sarcomas -- 49. Leukemias 50. Lymphomas -- 51. Multiple Myeloma and Cardiac Amyloidosis -- 52. Carcinoid 53. Cardiac Masses Part IV. Cancer Drugs 54. Cancer Therapeutic Drug Guide.
650			_aCancer Traitement Complications et séquelles
650			_aHeart Diseases
650			_a Cœur Maladies Étiologie
942			_2lcc _cBK _xMA
999			_c40062 _d40062